Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nextcea is a specialized contract research organization (CRO) providing high-quality bioanalytical services to the pharmaceutical and biotechnology industries. The company focuses on the application of advanced mass spectrometry and liquid chromatography (LC-MS/MS) for the quantification of small molecules, proteins, and biomarkers. Nextcea supports drug discovery and development programs by offering method development, validation, and sample analysis under GLP-compliant conditions. Their expertise extends to complex biologics, including monoclonal antibodies and oligonucleotides, helping clients navigate the bioanalytical challenges of modern drug modalities. The firm is recognized for its ability to handle difficult assays and provide rapid turnaround times for critical data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nextcea.